Optimization of stroke prophylaxis strategies in nonvalvular AF - Drugs, devices or both?

Amit Noheria, Faisal F. Syed, Christopher V. De Simone, Samuel J. Asirvatham

Research output: Contribution to journalReview articlepeer-review

Abstract

Atrial fibrillation (AF) is the most common cardiac arrhythmia with the prevalence increasing over time. AF probably afflicts ≥2% of worldwide adult population and increases with age.1-3 In the Framingham Heart Study, the lifetime risk of having at least one episode of AF for 40-year-old men and women was 26% and 23% respectively.4.

Original languageEnglish
Pages (from-to)71-80
Number of pages10
JournalJournal of Atrial Fibrillation
Volume8
Issue number2
StatePublished - Aug 1 2015

Keywords

  • Anticoagulation
  • Defibrillation
  • Device
  • Stroke

Fingerprint

Dive into the research topics of 'Optimization of stroke prophylaxis strategies in nonvalvular AF - Drugs, devices or both?'. Together they form a unique fingerprint.

Cite this